Luspatercept Disease Interactions
There are 3 disease interactions with luspatercept.
Luspatercept (applies to luspatercept) renal/liver
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease, Renal Dysfunction
Pharmacokinetic studies of luspatercept demonstrated no clinically significant differences in patients with mild to severe hepatic impairment and in patients with mild to moderate renal impairment. The effect of severe renal impairment on luspatercept pharmacokinetics is unknown. Care is recommended.
Luspatercept (applies to luspatercept) thromboembolism
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Thrombotic/Thromboembolic Disorder
Thromboembolic events (TEE) have been reported in luspatercept-treated patients with beta-thalassemia. Patients with known risk factors for thromboembolism may be at increased risk of thromboembolic events. It is recommended to monitor patients for signs and symptoms of thromboembolic events and consider thromboprophylaxis in patients with beta-thalassemia at increased risk of TEE.
Luspatercept – hypertension
Moderate Potential Hazard, Moderate plausibility.
The use of luspatercept may cause hypertension. It is recommended to monitor blood pressure before each dose administration. New-onset hypertension or exacerbation of preexisting hypertension should be managed with anti-hypertensive drugs as clinically appropriate.
Switch to professional interaction data
Luspatercept drug interactions
There are 2 drug interactions with luspatercept.
Luspatercept alcohol/food interactions
There is 1 alcohol/food interaction with luspatercept.
More about luspatercept
- luspatercept consumer information
- Check interactions
- Compare alternatives
- Reviews (10)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous erythropoiesis agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Procrit
Procrit is a man-made protein used to treat anemia caused by chronic kidney disease, chemotherapy ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Vitamin B6
Vitamin B6 is used for anemia, dietary supplementation, drug induced vitamin/mineral deficiency ...
Epogen
Epogen is used to treat anemia (a lack of red blood cells in the body). Learn about side effects ...
Retacrit
Retacrit is used for anemia, anemia due to chronic kidney disease, anemia prior to surgery, anemia ...
Reblozyl
Reblozyl is used to treat anemia in adults with beta-thalassemia or myelodysplastic syndromes ...
Azacitidine
Azacitidine systemic is used for acute myeloid leukemia, myelodysplastic syndrome
Epoetin alfa
Epoetin alfa systemic is used for anemia, anemia due to chronic kidney disease, anemia prior to ...
Lenalidomide
Lenalidomide (Revlimid) is used to treat multiple myeloma, mantle cell lymphoma, follicular ...
Ferrous gluconate
Ferrous gluconate systemic is used for anemia, anemia due to chronic kidney disease, iron ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.